ADO and neoplasm: In this review, we offer a comprehensive summary and in-depth discussion on the inhibition of ADO pathway by nanomedicines in tumor immunotherapy, focusing on the immunosuppressive mechanism of ADO and the application of nanomaterials targeting ADO pathway to boost immunotherapy (Figure 1).